BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18192126)

  • 21. Minnesota Department of Human Services audit of medication therapy management programs.
    Smith S; Cell P; Anderson L; Larson T
    J Am Pharm Assoc (2003); 2013; 53(3):248-53. PubMed ID: 23699672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Going out on your own: how to determine the value of your clinical services.
    Martin CM
    Consult Pharm; 2009 Nov; 24(11):817-22. PubMed ID: 20092219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic evaluation of pharmacist-led medication reviews in residential aged care facilities.
    Hasan SS; Thiruchelvam K; Kow CS; Ghori MU; Babar ZU
    Expert Rev Pharmacoecon Outcomes Res; 2017 Oct; 17(5):431-439. PubMed ID: 28825502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preliminary evaluation of medication therapy management services in assisted living facilities in rural Minnesota.
    Scott DM; Dewey MW; Johnson TA; Kessler ML; Friesner DL
    Consult Pharm; 2010 May; 25(5):305-19. PubMed ID: 20497929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pharmacists' role in the Patient-Centered Medical Home (PCMH): a white paper created by the Health Policy Committee of the Pennsylvania Pharmacists Association (PPA).
    Berdine H; Dougherty T; Ference J; Karpa K; Klootwyk J; Kozminski M; Leon N; Osborne M; Welch AC; Willey VJ; Peterson A; Stanchak LA; Whisler AG
    Ann Pharmacother; 2012 May; 46(5):723-50. PubMed ID: 22535839
    [No Abstract]   [Full Text] [Related]  

  • 26. Health care reform and the role of the pharmacist.
    Simenson S; Nau DP; Reed B
    J Am Pharm Assoc (2003); 2009; 49(3):356, 360-2. PubMed ID: 19443316
    [No Abstract]   [Full Text] [Related]  

  • 27. New York pharmacists push for CDTM.
    Traynor K
    Am J Health Syst Pharm; 2013 Nov; 70(21):1870, 1872. PubMed ID: 24128953
    [No Abstract]   [Full Text] [Related]  

  • 28. Financial oversight of medication use: an expanded role for consultant pharmacists.
    Stefanacci RG
    Consult Pharm; 2012 Apr; 27(4):290-5. PubMed ID: 22498989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What are you doing for others?
    Scott BE
    Am J Health Syst Pharm; 2019 Sep; 76(18):1377-1382. PubMed ID: 31505563
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacist-directed care to optimize medication use: a healthcare imperative in the United States.
    Watanabe JH
    Expert Rev Pharmacoecon Outcomes Res; 2020 Oct; 20(5):419-421. PubMed ID: 32902351
    [No Abstract]   [Full Text] [Related]  

  • 31. Integrating pharmacogenomics into pharmacy practice via medication therapy management.
    Reiss SM;
    J Am Pharm Assoc (2003); 2011; 51(6):e64-74. PubMed ID: 22001957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacist Role in Transitions of Care.
    Consult Pharm; 2017 Oct; 32(10):645-649. PubMed ID: 28992825
    [No Abstract]   [Full Text] [Related]  

  • 33. Consumer, physician, and payer perspectives on primary care medication management services with a shared resource pharmacists network.
    Smith M; Cannon-Breland ML; Spiggle S
    Res Social Adm Pharm; 2014; 10(3):539-53. PubMed ID: 24055137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analyzing the costs to deliver medication therapy management services.
    Rupp MT
    J Am Pharm Assoc (2003); 2011; 51(3):e19-26; quiz e27. PubMed ID: 21555277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Report of the 2009 APhA House of Delegates: actions of the legislative body of the American Pharmacists Association.
    J Am Pharm Assoc (2003); 2009; 49(4):492-4. PubMed ID: 19589759
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacists' performance of clinical interventions during adherence support medication reviews.
    Hatah E; Tordoff J; Duffull SB; Braund R
    Res Social Adm Pharm; 2014; 10(1):185-94. PubMed ID: 23688540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient-centered health care using pharmacist-delivered medication therapy management in rural Mississippi.
    Ross LA; Bloodworth LS
    J Am Pharm Assoc (2003); 2012; 52(6):802-9. PubMed ID: 23229968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of medication-related problems and health care provider acceptance of pharmacist recommendations in the DiabetesCARE program.
    DeName B; Divine H; Nicholas A; Steinke DT; Johnson CL
    J Am Pharm Assoc (2003); 2008; 48(6):731-6. PubMed ID: 19019801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reimbursement for clinical services provided by pharmacists: what are we doing wrong?
    Dole EJ; Murawski MM
    Am J Health Syst Pharm; 2007 Jan; 64(1):104-6. PubMed ID: 17189588
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of the pharmaceutical case management program implemented in a private sector health plan.
    Witry MJ; Doucette WR; Gainer KL
    J Am Pharm Assoc (2003); 2011; 51(5):631-5. PubMed ID: 21896463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.